A Model of Prefilled Syringes Exposure to Vapor Phase Hydrogen Peroxide (VPHP).
A model was developed that can be used to predict how hydrogen peroxide (H2O2) transfers into a liquid drug product that is exposed to Vapor Phase Hydrogen Peroxide (VPHP). This model accounts for fluid flow in both the gas and liquid phases as well as the diffusion and convection mechanisms of mass transfer using first principles of engineering to predict the amount of hydrogen peroxide that will transfer from the gas to liquid phase considering a given geometrical system and surrounding conditions. The model was used to investigate how much space you need in a given container to eliminate convective mass transfer and create a balance between mass transfer and air / liquid interface for oxidation sensitive products in cartridges or vials being filled in an isolator. Experimental results compare well with model predictions. A no-slip boundary condition between the gas and liquid phases was used for the model, which was especially important for the full syringes where convective mass transport predominated. This model may be used to evaluate isolator designs for filling oxidation-sensitive products utilizing the correlation between spiking studies and VPHP uptake to minimize the uptake studies required. It could also be used to inform the design of containers to be used that would minimize potential for VPHP uptake. For the geometry tested here, it was demonstrated that convection only occurs near the top few millimeters of the container. If the fill level is lower, as it would be for a syringe, the diffusion mechanism of transfer predominates and the rate of transfer of H2O2 is much slower. The balance between mass transfer by convection and diffusion should be a consideration in the design of the system to be filled.